Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Active
HT942526BCRPBTA122Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Department of Defense, through the Defense Health Agency Contracting Activity, is soliciting applications for the Fiscal Year 2026 Breast Cancer Research Program Breakthrough Award Levels 1 and 2. This initiative supports high-impact research aimed at achieving breakthroughs in breast cancer, requiring all applications to address specific overarching challenges or provide a strong justification for an exception. The program offers two funding levels, with Level 2 including a Population Science Studies option that may qualify for increased funding and an extended performance period. Eligible applicants may apply as a single Principal Investigator or as a partnership between an Initiating PI and a Partnering PI. For those utilizing the partnering option, the Initiating PI must submit the pre-application, while both must submit full applications to avoid administrative withdrawal. The response deadline for this solicitation is November 18, 2026.

General Info

DHA seeks FY2026 Breast Cancer Research Breakthrough Award applications by November 18, 2026.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.


Distinctive Features:


* This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.


* This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Synthetic Training Environment (STE) Virtual Software (VSW)
Solicitation # STE-VSW-26-0006
The Army Contracting Command-Aberdeen Proving Grounds Orlando Division, on behalf of the Capability Program Executive Simulation, Training, Test and Threat, is issuing a Call for Solutions for the Synthetic Training Environment Virtual Software under Army Open Solicitation W9128Z-25-S-1002. The objective is to identify a rapid, cost-effective, and technically sound solution to achieve four primary operational outcomes: a doctrinal gate to live fire, a true combined arms environment, full mission command concurrency, and an open system architecture with published SDKs and APIs. The total combined value of all awarded lots is approximately 250 million dollars. The scope is divided into five capability lots, including a foundational software platform, specialized applications, hardware-in-the-loop integration and test, and enterprise integration support. The acquisition process follows a phased selection approach based on technical merit, schedule achievability, and relevant experience within the last three years. Key technical requirements include native ingestion of One World Terrain data, alignment with TC 3-20.0 Integrated Weapons Training Strategy, and a secure by design foundation leveraging FedRAMP authorizations to accelerate the RMF Open Network Authority to Operate timeline. A strict organizational conflict of interest firewall is established for the Lot 5 integration support vendor, prohibiting them from proposing on other lots. The selection process includes a blind technical submission to ensure impartial assessment, followed by demonstrations and a final award anticipated by November 6, 2026.
W6QK Acc-Apg-Orlando

POSTED

about 13 hours ago

DEADLINE

in 18 days
View Details
NAICS: 541715
New
Federal
Selective Harnessing of Intrinsic Neuroplasticity Engineering (SHINE)
Solicitation # DARPA-PA-25-07-06
The Selective Harnessing of Intrinsic Neuroplasticity Engineering (SHINE) program, issued by the DARPA Defense Sciences Office under solicitation DARPA-PA-25-07-06, seeks innovative basic and applied research to selectively induce adaptive neuroplasticity within specific brain cell-types, regions, or circuits. This 18-month effort is divided into two tracks: Track A focuses on translationally mature technologies aimed at imminent clinical trials, requiring a therapeutic index of 5 or greater and the use of quantitative biomarkers such as fMRI or PET. Track B targets foundational, high-risk concepts ready for animal testing, requiring a spatial containment threshold exceeding 90 percent. All awards will be executed as Other Transaction (OT) for Prototype Agreements with a maximum value of 2,000,000 dollars per award, including any performer cost share. The program follows a synchronized timeline starting in January 2027, featuring a critical evaluation point at month 9 to assess progress through technical data and site visit demonstrations. Proposers must adhere to strict cybersecurity requirements, including a current CMMC status and annual affirmation posted in the Supplier Performance Risk System. Additionally, University Affiliated Research Centers acting as primes or subawardees must provide an organizational conflict of interest mitigation plan, and FFRDCs must certify that their proposed work is unavailable from the private sector. Proposals must be submitted as zip files via the DARPA BAA T Portal by October 9, 2026, utilizing the required Task Description Document templates and the Streamlined Cost Buildup Workbook.
Defense Advanced Research Projects Agcy

POSTED

about 13 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
New
Federal
ARMY OPEN SOLICITATION (AOS)
Solicitation # W9128Z-25-S-A002
The Army Open Solicitation (AOS), solicitation number W9128Z-25-S-A002, is an indefinite open solicitation issued by the U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG) Digital Capability Contracting Center of Excellence. Its primary objective is to support all Army mission areas and maximize Army lethality by rapidly acquiring innovative commercial technologies, research and development solutions, and software acquisition pathway procurements. The AOS leverages a broad range of authorities, including FAR 6.102(d)(2), FAR 35.016 Broad Agency Announcements, and various 10 U.S.C. sections for prototypes and experimental procurements, as well as the Commercial Solutions Opening (CSO) process. Interested parties can engage through two primary methods: responding to Active Capability Gaps (ACG) or submitting proposals in response to specific Calls for Solutions. The award process generally follows a multi-phase approach consisting of a Solution Brief, a Live Pitch, and a final Solution Proposal. Evaluation is based on a hierarchy of Technical Merit, Viability, Feasibility and Desirability, and Schedule and Price. All submissions must be unclassified, and the government does not reimburse companies for costs incurred during the initial three phases of the solicitation process. Key administrative requirements include mandatory registration in the System for Award Management (SAM) and the use of the Wide Area Work Flow (WAWF) for invoicing. Security requirements mandate that all government data reside within the exclusive legal jurisdiction of the United States. Solution Briefs are strictly limited to five written pages in 12-point font or fifteen briefing slides and must be submitted as a single PDF document. While the overall AOS remains open in perpetuity until canceled, individual Calls for Solutions have specific, limited response windows.
W6QK Acc-Apg Contr Ctr

POSTED

about 13 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Chemistry Research for the Division of Translational Toxicology (DTT)
Solicitation # 75N94026R00002
Solicitation 75N94026R00002 is a request for proposals to provide comprehensive chemistry research support for the National Institute of Environmental Health Sciences Division of Translational Toxicology and the National Toxicology Program. The contract aims to support the toxicological evaluation process through eight functional areas: logistics and handling, characterization, formulation, biosample analysis, special studies, animal studies, omics, and in vitro assays. This is a multiple-year cost-reimbursement type completion contract with a base period of one year and nine subsequent 12-month options, plus a potential six-month extension, spanning a contemplated period of performance from January 18, 2027, to January 17, 2037. The government will award the contract based on best value, where technical factors and past performance are significantly more important than cost. Technical evaluation focuses on experience, program management, technical approach, personnel, facilities, and small business utilization, while past performance is weighted equally to the combined technical factors. Key requirements include the appointment of a Principal Investigator and Deputy PI, strict adherence to FDA Good Laboratory Practices for nonclinical laboratory studies, and compliance with cybersecurity and supply chain risk management policies. Proposals must be submitted electronically via the NIH eCPS website by September 14, 2026.
National Institutes Of Health Nichd

POSTED

about 13 hours ago

DEADLINE

in 11 days
View Details
NAICS: 541715
New
Federal
Uncrewed Aircraft Systems (UAS) Services
Solicitation # 1305M226Q0069
This Multiple Award Indefinite Delivery, Indefinite Quantity (IDIQ) contract, solicitation number 1305M226Q0069, is a 100 percent small business set-aside for women-owned small businesses under NAICS 541715. The Department of Commerce, through the National Oceanic and Atmospheric Administration (NOAA) Office of Marine and Aviation Operations, is seeking Uncrewed Aircraft Systems (UAS) Data-as-a-Service (DaaS) to support the Autonomous UxSOC Technology Operations program. The contract features a five-year ordering period with a shared total estimated ceiling of 7,500,000.00 dollars, utilizing Firm-Fixed Price task orders. The scope of work involves providing fully supported UAS missions, personnel, and equipment to collect operational data across several mission areas, including living marine resource surveys, meteorological and oceanographic observations, ocean exploration, and hydrographic mapping. Performance may occur anywhere within or outside the United States National Airspace System, with specific locations defined at the task order level. Key deliverables include raw and processed mission data sets, real-time data streams via secure API or cloud transfer, monthly progress reports, and sensor calibration logs traceable to NIST standards. Contractors must provide a Quality Control Plan within 30 days of award and demonstrate FAA compliance for Beyond Visual Line of Sight operations through waivers or Detect and Avoid technologies. Awards are based on a best-value tradeoff analysis, prioritizing demonstrated prior experience and technical capability over price. The procurement process follows a two-step advisory down-select procedure, with initial submissions due by September 9, 2026, and final technical and price quotes due by September 30, 2026.
Ead-Omao

POSTED

about 21 hours ago

DEADLINE

in 8 days
View Details
NAICS: 541715
New
Federal
REQUEST FOR INFORMATION - OPERATIONAL TEST AND TRAINING READINESS DIVISION - DevSecOps
Solicitation # OTTI_2026_RFI_SpecDevOps
Space Systems Command is conducting market research through a Request for Information to evaluate the feasibility of a no-cost Prototype Other Transaction Agreement under 10 U.S.C. section 4022. The primary objective is to design, engineer, and validate a secure, multi-node, multi-vendor continuous software development and delivery architecture. This prototype aims to connect commercially owned and operated secure facility nodes directly to secure Government cloud environments, enabling scalable DevSecOps pipelines and improving software accreditation and deployment reliability by overcoming high-to-low security boundary bottlenecks. The project utilizes a two-phase approach, starting with a public phase to identify commercial capabilities followed by a controlled phase for vetted vendors under non-disclosure agreements. Participating vendors must be entirely U.S.-owned and operated, maintain a Facility Security Clearance, and provide 100% of the cost-share for physical facilities and cleared personnel. Technical requirements include the use of DevOps toolchains, containerization, and Kubernetes. Successful demonstration of a secure connection and software transmission may lead to potential sole-source follow-on production contracts. Interested parties must submit a white paper of no more than five pages by September 11, 2026, including specific business information and security posture details submitted via secure channels.
FA2553 Oprn Testing & Trg Infr Otti Pk

POSTED

1 day ago

DEADLINE

in 8 days
View Details

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541715
Grant
DoW Reconstructive Transplant, Investigator-Initiated Research Award
Solicitation # HT942526RTRPIIRA
The fiscal year 2026 Reconstructive Transplant Research Program Investigator-Initiated Research Award, solicitation HT942526RTRPIIRA, is a funding opportunity from the Defense Health Agency designed to advance the science and clinical practice of vascularized composite allotransplantation. The program supports research ranging from basic to translational phases, including preclinical animal models and clinical research involving human subjects, provided that the projects are not clinical trials. All proposed studies must demonstrate a solid scientific rationale, include relevant preliminary or published data, and show direct utility for the healthcare needs of military Service Members, Veterans, their caregivers, or the general public. Awards are capped at 1.0 million dollars with a maximum period of performance of three years. Applications must be submitted through the Electronic Biomedical Research Application Portal by November 4, 2026, following a pre-application letter of intent due October 21, 2026. The evaluation process consists of a two-tier review: a peer review based on scored criteria such as study design, statistical plan, impact, and personnel, followed by a programmatic review for military relevance and portfolio composition. Applicants must be registered in SAM.gov and provide comprehensive documentation, including a project narrative, statement of work, and a post-award transition plan. Key requirements include the disclosure of foreign affiliations for all key personnel and a strategy for the inclusion of women and minorities in clinical research.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

in 2 months
View Details